J2KBIO Co., Ltd. (KOSDAQ:420570)
11,190
+630 (5.97%)
At close: Aug 11, 2026
12.35% (1Y)
| Market Cap | 65.43B +12.3% |
| Revenue (ttm) | 36.82B +13.0% |
| Net Income | 4.03B +39.4% |
| EPS | 690.98 +36.0% |
| Shares Out | 5.85M |
| PE Ratio | 16.19 |
| Forward PE | n/a |
| Dividend | 250.00 (2.37%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 67,071 |
| Open | 10,720 |
| Previous Close | 10,560 |
| Day's Range | 10,560 - 11,290 |
| 52-Week Range | 6,710 - 11,850 |
| Beta | 0.28 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 12, 2026 |